Trafalgar International (GCAN) Cash from Operations (2017 - 2026)
Greater Cannabis Company (GCAN) posted quarterly Cash from Operations of 4376.0 for Q1 2026, up 60.77% year-over-year from 2721.88 in Q1 2025, and up 81.87% quarter-over-quarter from 24140.0 in Q4 2025.
Trafalgar International (GCAN) Cash from Operations (2017 - 2026) Analysis & Trends
Greater Cannabis Company's Cash from Operations history runs 10 years deep, the most recent figure standing at 4376.0 for Q1 2026.
- In Q1 2026, Cash from Operations rose 60.77% year-over-year to 4376.0; the TTM figure through Mar 2026 stood at 53374.0 (up 35.78% YoY), while the FY2025 annual figure was 60153.0, up 45.06% from the prior year.
- Cash from Operations for Q1 2026 stood at 4376.0, up from 24140.0 in the prior quarter.
- The five-year high for Cash from Operations was 4376.0 in Q1 2026, with the low at 56392.0 in Q2 2022.
- The 5-year median for Cash from Operations is 19064.0 (2022), against an average of 22628.29.
- The sharpest annual moves came in 2024 and 2025: Cash from Operations soared 84.96% in 2024, then tumbled 391.25% in 2025.
- Greater Cannabis Company's Cash from Operations stood at 19064.0 in 2022, then slumped by 71.39% to 32673.0 in 2023, then jumped by 84.96% to 4914.0 in 2024, then slumped by 391.25% to 24140.0 in 2025, then surged by 81.87% to 4376.0 in 2026.
- Business Quant data shows GCAN's Cash from Operations at 4376.0 in Q1 2026, 24140.0 in Q4 2025, and 5357.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Trafalgar International | 236,233.75 | 236,233.75 | - | -4,376.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,376.00 |
| Mar 31, 2026 | -4,376.00 |
| Dec 31, 2025 | -24,140.00 |
| Dec 31, 2025 | -24,140.00 |
| Sep 30, 2025 | -5,357.00 |
| Sep 30, 2025 | -5,357.00 |
| Jun 30, 2025 | -19,501.00 |
| Jun 30, 2025 | -19,501.00 |
| Mar 31, 2025 | -11,155.00 |
| Mar 31, 2025 | -11,155.00 |
| Dec 31, 2024 | -4,914.00 |
| Dec 31, 2024 | -4,914.00 |
| Sep 30, 2024 | -18,034.00 |
| Sep 30, 2024 | -18,034.00 |
| Jun 30, 2024 | -49,007.00 |
| Jun 30, 2024 | -49,007.00 |
| Mar 31, 2024 | -37,536.00 |
| Mar 31, 2024 | -37,536.00 |
| Dec 31, 2023 | -32,673.00 |
| Dec 31, 2023 | -32,673.00 |